Rubicon Research Limited

DecreasedSAST

RUBICONHealthcareMarket Cap₹29K Cr

Value

₹2,325 Cr

1,40,00,000

Price

₹1,660.73

Stake

35.79% → 27.34%

General Atlantic Singapore RR Pte Ltd

Promoter

The move

General Atlantic Singapore RR Pte Ltd, a promoter of Rubicon Research Limited, sold 1.4 crore shares for ₹2325.03 Cr at ₹1660.73 apiece in a market sale, decreasing its stake from 35.79% to 27.34%.

About Rubicon Research Limited

Visit stock

A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.

Get the next move the moment it happens.

Follow the investors and Rubicon Research Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Rubicon Research Limited shareholders All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Rubicon Research Limited

GIRISH SUBRAMANIAM IYER

Direction, size, price and stake change for this move, with what it means for the company.

8 Sept 2026. Sign in to see this move

General Atlantic Singapore RR Pte. LtdDecreased

Promoter General Atlantic Singapore RR Pte. Ltd. sold 1.4 crore shares of Rubicon Research on the open market, trimming its stake from 35.45% to 27.07%.